cetirizine hydrochloride and pseudoephedrine hydrochloride
Generic: cetirizine hydrochloride, pseudoephedrine hydrochloride
Labeler: padagis israel pharmaceuticals ltdDrug Facts
Product Profile
Brand Name
cetirizine hydrochloride and pseudoephedrine hydrochloride
Generic Name
cetirizine hydrochloride, pseudoephedrine hydrochloride
Labeler
padagis israel pharmaceuticals ltd
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
Active Ingredients
cetirizine hydrochloride 5 mg/1, pseudoephedrine hydrochloride 120 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
45802-147
Product ID
45802-147_1e179f00-1e00-4199-bf78-bb00aa268c74
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA210719
Listing Expiration
2026-12-31
Marketing Start
2020-03-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
45802147
Hyphenated Format
45802-147
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cetirizine hydrochloride and pseudoephedrine hydrochloride (source: ndc)
Generic Name
cetirizine hydrochloride, pseudoephedrine hydrochloride (source: ndc)
Application Number
ANDA210719 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 120 mg/1
Packaging
- 12 BLISTER PACK in 1 CARTON (45802-147-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
- 24 BLISTER PACK in 1 CARTON (45802-147-62) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1e179f00-1e00-4199-bf78-bb00aa268c74", "openfda": {"unii": ["64O047KTOA", "6V9V2RYJ8N"], "rxcui": ["1014571"], "spl_set_id": ["3260111b-35da-4f95-8081-51eae4b1ef45"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BLISTER PACK in 1 CARTON (45802-147-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "45802-147-53", "marketing_start_date": "20200331"}, {"sample": false, "description": "24 BLISTER PACK in 1 CARTON (45802-147-62) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "45802-147-62", "marketing_start_date": "20200331"}], "brand_name": "Cetirizine hydrochloride and Pseudoephedrine hydrochloride", "product_id": "45802-147_1e179f00-1e00-4199-bf78-bb00aa268c74", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "alpha-Adrenergic Agonist [EPC]"], "product_ndc": "45802-147", "generic_name": "Cetirizine hydrochloride, Pseudoephedrine hydrochloride", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Cetirizine hydrochloride and Pseudoephedrine hydrochloride", "active_ingredients": [{"name": "CETIRIZINE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "PSEUDOEPHEDRINE HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA210719", "marketing_category": "ANDA", "marketing_start_date": "20200331", "listing_expiration_date": "20261231"}